1. cancer statistics;Siegel;CA Cancer J Clin 64(1),2014
2. Cancer Statiastics;Siegel;CA Cancer J Clin 65(1),2015
3. Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab;Nishino;Cancer Imaging,2012
4. The BATTLE trial: personalizing therapy for lung cancer;Kim;Cancer Discov 1(1),2011
5. Nelson V, Ziehr J, Agulnik M, Johnson M (2013) Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC. Onco Targets Ther 6:135-143.